0000899243-17-023603.txt : 20171004
0000899243-17-023603.hdr.sgml : 20171004
20171004200208
ACCESSION NUMBER: 0000899243-17-023603
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170929
FILED AS OF DATE: 20171004
DATE AS OF CHANGE: 20171004
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLINOIS XAVIER
CENTRAL INDEX KEY: 0001230718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21244
FILM NUMBER: 171123045
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PAREXEL INTERNATIONAL CORP
CENTRAL INDEX KEY: 0000799729
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 042776269
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 7814879900
MAIL ADDRESS:
STREET 1: 195 WEST ST
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-29
1
0000799729
PAREXEL INTERNATIONAL CORP
PRXL
0001230718
FLINOIS XAVIER
C/O PAREXEL INTERNATIONAL CORPORATION
195 WEST STREET
WALTHAM
MA
02451
0
1
0
0
President, PAREXEL Informatics
Common Stock
2017-09-29
4
D
0
17613
D
0
D
Restricted Stock Units
0.00
2017-09-29
4
U
0
1551
0.00
A
2018-12-31
Common Stock
1551
2000
D
Restricted Stock Units
0.00
2017-09-29
4
U
0
2000
88.10
D
2017-09-10
2018-12-31
Common Stock
2000
0
D
Restricted Stock Units
0.00
2017-09-29
4
U
0
1539
0.00
A
2019-12-31
Common Stock
1539
1900
D
Restricted Stock Units
0.00
2017-09-29
4
U
0
1900
88.10
D
2019-12-31
Common Stock
1900
0
D
Restricted Stock Units
0.00
2017-09-29
4
U
0
800
88.10
D
2017-09-10
2017-12-31
Common Stock
800
0
D
Restricted Stock Units
0.00
2017-09-29
4
U
0
3700
88.10
D
2019-12-31
Common Stock
3700
0
D
Stock Options (Right to Buy)
67.00
2017-09-29
4
U
0
6300
14.00
D
2024-09-14
Common Stock
6300
0
D
Stock Options (Right to Buy)
66.58
2017-09-29
4
U
0
8900
21.52
D
2023-09-09
Common Stock
8900
0
D
Stock Options (Right to Buy)
48.69
2017-09-29
4
U
0
3700
39.41
D
2021-09-11
Common Stock
3700
0
D
Stock Options (Right to Buy)
33.85
2017-09-29
4
U
0
10000
54.25
D
2021-02-01
Common Stock
10000
0
D
Stock Options (Right to Buy)
57.93
2017-09-29
4
U
0
8200
30.17
D
2022-09-10
Common Stock
8200
0
D
Disposed of pursuant to the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017 (the "Merger Agreement"), whereby, at the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of the Issuer's common stock were automatically cancelled and converted into the right to receive $88.10 per share in cash without interest (the "Merger Consideration").
Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration.
These restricted stock units were to vest in full on September 14, 2019.
These restricted stock units were to vest in full on September 9, 2018.
Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time.
Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/14/2016.
Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/09/2019.
Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/11/2013.
Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 02/01/2013.
Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/10/2018.
/s/ Douglas Batt, as Attorney-in-Fact for Xavier Flinois
2017-10-04